Delivery Order SPE2DB25D3020-SPE2DB25FWKAV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- This delivery order, awarded on July 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Opzelura 1.5% Cream in 60-gram units with a ceiling value of $1,310.45. The award represents a firm fixed-price delivery order under a non-competitive, non-set-aside procurement, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format, with a ceiling value of $2,046.89. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order carries...
- The Defense Logistics Agency awarded a $23,120.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram quantities, with a completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.99 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60gm), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This non-set-aside, firm fixed price delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. The award represents a child contract action under AmerisourceBergen's broader relationship with the federal government as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,358.40 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be performed at AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram quantities. The contract is valued at $14,900.19 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competitive procurement. Performance will be completed by August 6, 2025, with work performed...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,755.69 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units. This firm fixed-price, competitive contract (no set-aside designation) was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKAVDelivery Order
The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, holds a significant position as a federal medical procurement vendor. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Opzelura, a topical dermatological medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for military and federal healthcare needs through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/15/25 |